ACC 2024|4.6-8 三场特色研究专场即将开启,FCR日程一览!

4月6-8日(美国时间),第73届美国心脏病学会年度科学会议(ACC.24)将以线上线下结合的形式在美国亚特兰大举办。

本届年会设置5场最新揭晓的临床试验(Late-Breaking Clinical Trials,LBCTs)专场和3场特色临床研究(Featured Clinical Research,FCR)专场,将公布38项突破性研究成果。目前官网日程已正式上线,严道医声网特别进行整理,供广大读者参考。

点击查看LBCTs日程


FCR专场日程如下:


Session 403|Featured Clinical Research I

北京时间:4月7日 4:15-5:30 am

当地时间:Saturday, April 6;4:15-5:30 pm

线下参会:Murphy Ballroom 4

1.Comparison of an "Inclisiran First" Strategy With Usual Care in Patients With Atherosclerotic Cardiovascular Disease: Results From the VICTORION-INITIATE Randomized Trial

1.动脉粥样硬化心血管疾病患者中对比首选小干扰RNA(siRNA) “Inclisiran”的治疗策略与常规治疗策略:来自VICTORION-INITIATE随机试验的结果

2.Targeting Weight Loss to Personalize the Prevention of Type 2 Diabetes

2.以减重为目标的个体化2型糖尿病的预防

3.Once-weekly Semaglutide in Patients With Heart Failure With Preserved Ejection Fraction, Obesity and Type 2 Diabetes: Main Results From the Step-HFpEF Dm Trial

3.合并肥胖和2型糖尿的射血分数保留心力衰竭患者中每周用药一次的司美格鲁肽的治疗效果:来自Step-HFpEF Dm试验的主要结果

4.Mandibular Advancement Device Versus CPAP For Blood Pressure Reduction in Obstructive Sleep Apnea and High Cardiovascular Risk─ A Randomized Clinical Non-inferiority Trial

4.阻塞性睡眠呼吸暂停和高心血管风险患者中对比下颌前移矫治器与CPAP的降压效果:一项随机临床非劣效试验

5.Remote Acute Assessment of Patients With High Cardiovascular Risk Post-acute Coronary Syndrome (TELE-ACS)

5.高心血管风险的急性冠状动脉综合征患者的远程急性评估(TELE-ACS)


Session 407|Featured Clinical Research II

北京时间:4月8日 0:15-1:30 am

当地时间:Sunday, April 7;12:15-1:30 pm

线下参会:Main Tent (Hall B1)

6.Benzodiazepine-free Cardiac Anesthesia For Reduction of Postoperative Delirium (B-Free): A Multi-centre Randomized Cluster Crossover Trial

6.无苯二氮䓬类心脏麻醉药物是否减少术后谵妄(B-Free):一项多中心随机区组交叉试验

7.The Diabetes Remote Intervention to Improve Use of Evidence-based Medications (DRIVE) Study: A Randomized Evaluation of a Team-based Remote Education and Medication Management Program to Reduce CV and Kidney Risk

7.改善2型糖尿病患者的基于证据的药物的使用情况的远程干预(DRIVE)研究:一项关于以团队为基础的远程教育和药物治疗计划、旨在降低心血管和肾脏风险的随机评估

8.Improving Cardiac Rehabilitation Participation in Lower-socioeconomic Status Patients: Case Management Vs. Financial Incentives

8.改善低社会经济地位患者的心脏康复参与情况:病例管理 vs. 经济刺激

9.Impact of Routine Assessment of Patient-Reported Health Status in Heart Failure Clinic (PRO-HF) Trial

9.在心力衰竭门诊进行的由患者报告的常规健康状况评估的影响(PRO-HF)

10.Restrictive Versus Liberal Blood Transfusion Strategy in Type 1 Versus Type 2 Myocardial Infarction: A Prespecified Subgroup Analysis From the Myocardial Ischemia and Transfusion (MINT) Trial

10.1型和2型心肌梗死患者中限制性 vs. 自由输血策略:来自心肌缺血和输血(MINT)试验的预先设定的亚组分析


Session 413|Featured Clinical Research III

北京时间:4月9日 0:45-2:00 am

当地时间:Monday, April 8;12:45-2:00 pm

线下参会:Room B406A

11.Fractional Flow Reserve-guided Complete or Culprit-only PCI in Patients With ST-elevation Myocardial Infarction

11.ST段抬高型心肌梗死患者中FR指导的完全血运重建PCI术vs.仅治疗于罪犯血管的PCI术

12.A Multicenter Prospective Randomized Study Comparing the Incidence of Periprocedural Cerebral Embolisms Caused by Catheter Ablation of Atrial Fibrillation Between Cryoballoon and Radiofrequency Ablation

12.房颤冷球囊消融和射频消融致围手术期脑栓塞的发生率的比较:一项多中心前瞻性随机对照研究

13.Transseptal Versus Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli (the TRAVERSE Trial)

13.经间隔穿刺 vs. 逆向主动脉心室入口对全身栓塞事件的影响(TRAVERSE试验)

14.Intravascular Ultrasound-guided Versus Angiography-guided Percutaneous Coronary Intervention in Acute Coronary Syndromes: The Multicenter, Randomized, Blinded, IVUS-ACS Trial

14. IVUS指导与造影指导的急性冠状动脉综合征患者的经皮冠状动脉介入治疗:多中心、随机、盲法IVUS-ACS试验

15.Protein and Exercise to Reverse Frailty in Older Men and Women Undergoing Transcatheter Aortic Valve Replacement: The PERFORM-TAVR Trial

15.蛋白质和运动改善行TAVR术治疗的老年男性和女性患者的虚弱状态:PERFORM-TAVR试验

届时,严道医声网小编也将直飞美国亚特兰大,走进会场,持续为您带来ACC.24会议动态,敬请持续关注!

来源:ACC官网

阅读数: 470